Poland· PL-100301218
Fluanxol
A flupentixol product containing flupentixolum, registered in Poland by H. Lundbeck A/S. The same ATC class is registered in 14 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Flupentixol is registered in 14 of 19 countries.
Countries holding a registration under ATC N05AF01 (flupentixol), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Flupentixol · ATC N05AF01
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of flupentixol costs, country by country.
Normalised to the WHO defined daily dose (6 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Flupentixol · price per daily dose (6 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.77
The record
At a glance
URPL (Poland)- Active substance
- Flupentixolum
- Manufacturer
- H. Lundbeck A/S
- Country
- Poland (PL)
- ATC code
- N05AF01
- ATC class
- Flupentixol
- Defined daily dose
- 6 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 4
1 priced- gtin0590999107429650 szt.PLN 39
- gtin05909991074272
- gtin05909991074289
- gtin05909991074302
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
26 interactions on record for flupentixol.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Flupentixol · interactions on record
26 records
26 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Flupentixol in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/887b6b23-18dc-48c2-90c4-9a83442eb8f5 GET /v1/drugs/887b6b23-18dc-48c2-90c4-9a83442eb8f5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "3 mg",
"packaging": "05909991074272 ¦ Rp ¦ 85382\n50 tabl. w blistrze\n05909991074289 ¦ Rp ¦ 85505\n100 tabl. w blistrze\n05909991074296 ¦ Rp ¦ 85506\n1 poj. 50 tabl.\n05909991074302 ¦ Rp ¦ 85507\n1 poj. 100 tabl.",
"substance": "Flupentixoli dihydrochloridum 3.504 mg",
"common_name": "Flupentixolum",
"pl_product_id": "100301218",
"pozwolenie_nr": "21553",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about flupentixol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.